person
as of 2026-07-01Biswa Ranjan Mishra, MD
ORCID 0000-0003-0537-9454
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 14
4 publications · 1 high-value
Cross-drug reach: 3 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Professor and Head, Department of Psychiatry
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
14
Publications
4 (1 high-value)
Trial investigator
yes
Publishes on
3 drugs
Trials led
1
Publications & congress
4
Efficacy and safety of low-dose amisulpride versus olanzapine-fluoxetine combination in post-schizophrenic depression: A randomized controlled trial.
Journal of psychiatric research · 2024 · high-value
Efficacy and Safety of Transcranial Alternating Current Stimulation Compared to Transcranial Direct Current Stimulation in the Treatment of Psychiatric & Neurological Disorders: A Systematic Review of Head-to-head Trials.
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026
Lumateperone as an alternative to clozapine in treatment-resistant schizophrenia: Insights from a quantitative systems pharmacology model.
The Journal of pharmacology and experimental therapeutics · 2026
A Bayesian network meta-analysis of randomized controlled trials comparing the efficacy and safety of cholinergic modulators in schizophrenia.
Journal of psychopharmacology (Oxford, England) · 2026
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on